{"id":"W4417004176","doi":"10.1182/blood-2025-3338","title":"Comparison of simulated exposure of inotuzumab ozogamicin with and without dose capping in overweight and obese patients with relapsed/refractory acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Body surface area; Regimen; Dosing; Pharmacokinetics; Phases of clinical research; Population; Antibody-drug conjugate; Acute lymphocytic leukemia; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000557232,0.000501712,0.0005869984,0.0002710293,0.0001991117,0.0006279923,0.0005221641,0.0009074463,0.001398522],"category_scores_gemma":[0.002203466,0.0003363526,0.00098464,0.000275698,0.00029803,0.0003053198,0.0003283892,0.0007253558,0.0001965374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009745706,"about_ca_system_score_gemma":0.000840881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01874514,"about_ca_topic_score_gemma":0.006070368,"domain_scores_codex":[0.9997974,0.00009450276,0.000007840896,0.00003753866,0.00002689476,0.00003575728],"domain_scores_gemma":[0.9988683,0.0007937645,0.0001264674,0.00003004726,0.0001167265,0.00006472604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001062472,0.0001290022,0.008673543,0.00005027894,0.00007233727,0.0001585962,0.00003449819,0.9856803,0.001497576,0.0003267022,0.0004169829,0.001897722],"study_design_scores_gemma":[0.0003213873,0.0008553001,0.006438003,0.00002084231,0.0001186437,0.00009754014,0.00007850219,0.9883772,0.002266991,0.0005435192,0.0008571765,0.00002497383],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922277,0.0002093514,0.003691908,0.0001613213,0.00001971594,0.00006106078,0.001157404,0.00007604343,0.002395346],"genre_scores_gemma":[0.9978909,0.00008220238,0.0008700305,0.0000523081,0.000003115214,0.00004822117,0.0005727049,0.00001277492,0.0004679161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01874514,"threshold_uncertainty_score":0.0372721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008184380537076581,"score_gpt":0.2727083277999659,"score_spread":0.2645239472628893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}